Comparison Of Clinical Outcomes of Intraperitoneal Bupivacaine Instillation Versus Placebo as Preemptive Analgesia in Patients Undergoing Open Appendectomy

ConditionAppendectomy
Trial statusRecruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age20-60
SponsorSardar Umer Rehman

About this trial

To compare the clinical outcomes of intraperitoneal bupivacaine instillation vs placebo as preemptive analgesia in patients undergoing open appendectomy

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients presenting to the emergency department undergoing open appendectomy.

Disqualifiers

Patients undergoing interval appendectomy or having perforated appendix as evident by examination (abdominal tenderness/ fever) and USG findings (presence of abscess, fluid collection, or free air).

Uncontrolled medical disease (DM: BSL >200mg/dl, HTN: BP >140/90)

History of chronic kidney or liver disease/ psychiatric illness/ Active peptic ulcer disease (as determined on history and medical records)

Alcoholics

Trial design

Design model

Parallel

Treatments tested in this trial

  • Bupivacain

    Drug

    Bupivacaine with 0.25% of concentration at the end of the operation intraperitoneally.

  • Normal Saline

    Other intervention

    10ml of Normal Saline at the end of the operation intraperitoneally.

Treatment groups

60 Participants
are divided into 2 treatment groups
Group A: Group A participants who will receive Bupivacaine IntraperitoneallyExperimental treatment 1 intervention
Group B: Group B participants who will receive 10 ml of normal saline IntraperitoneallyActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Post operative pain

Intensity of post operative pain by using visual analogue score and frequency of postoperative rescue analgesics if required after instillation of bupivacaine and placebo in both groups. Both outcomes will be noted at different intervals i.e. 2, 6, 12 and 24 hours postoperatively for comparison as mentioned.

Time frame
24 hours

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Sardar Umer Rehman

Lead sponsor

Services Institute of Medical Sciences, Pakistan

Sponsor institution

Services Institute of Medical Sciences, Pakistan

Collaborator